There is now a wealth of data supporting the role of NEAT1 in cancer biology, including the observation that loss or attenuation of NEAT1 occurs in many human malignancies, including bone tumours, breast cancer, lung cancer, liver cancer, ovarian cancer, pancreatic cancer and many haematological disorders. This evidence concerns the gene NEAT1 and cancer.